EUVIMEDEUVIMED entdecken
Crossref

Turning Tumor Acidosis into a Therapeutic Advantage with Nanomedicine

Ke Ren, Lihua Pang, Songyu Lv, Yuhang Ren, Liya Tian, Nengyi Ni, Xiao Sun, Junjie Cheng, Xinyu Zhang, Xueli Xu

ACS Nano Medicine · 11.02.2026 · 1 (1) · 74-96

DOI: 10.1021/acsnanomed.5c00021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano Medicine, online erschienen am 08.10.2025. Verfasst von Ke Ren und 9 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 183 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Department of Science and Technology of Shandong Province, Incubation Foundation of Shandong Provincial Hospital.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High Resolution Image Download MS PowerPoint Slide Malignant tumors pose a major threat to global health security, making the development of efficient antitumor drugs imperative. Tumor tissues are distinguished from normal human tissues by their unique acidic microenvironment, which is established via a transmembrane pH gradient driven by metabolic processes. As an emerging tumor-specific therapeutic strategy, disrupting abnormal tumor metabolism through intracellular acidification-induced acidosis has gained significant attention. This review systematically summarizes various strategies to enhance the antitumor efficacy of nanomedicine by inducing acidosis, including approaches to promote intracellular H + accumulation, inhibit H + efflux, and combinations of these methodologies. Furthermore, we present new insights into the synergistic therapeutic effects achieved by integrating acidosis with established treatment modalities such as chemodynamic therapy, radiotherapy, photothermal therapy, and immunotherapy. Finally, we discuss current challenges associated with tumor metabolism disruption through acidosis-based therapeutic approaches. This review aims to provide new perspectives on acidosis induction and offer new ideas for the future development of nanomedicine in cancer therapy.

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • Department of Science and Technology of Shandong Province
  • Incubation Foundation of Shandong Provincial Hospital

Zitieren

APA

Ren, K., Pang, L., Lv, S., Ren, Y., Tian, L., Ni, N., Sun, X., Cheng, J., Zhang, X., & Xu, X. (2026). Turning Tumor Acidosis into a Therapeutic Advantage with Nanomedicine. ACS Nano Medicine, 1(1), 74-96. https://doi.org/10.1021/acsnanomed.5c00021

Vancouver

Ren K, Pang L, Lv S, Ren Y, Tian L, Ni N, et al. Turning Tumor Acidosis into a Therapeutic Advantage with Nanomedicine. ACS Nano Medicine. 2026;1(1):74-96. doi:10.1021/acsnanomed.5c00021

BibTeX
@article{Ren2026,
  author = {Ren, Ke and Pang, Lihua and Lv, Songyu and Ren, Yuhang and Tian, Liya and Ni, Nengyi and Sun, Xiao and Cheng, Junjie and Zhang, Xinyu and Xu, Xueli},
  title = {Turning Tumor Acidosis into a Therapeutic Advantage with Nanomedicine},
  journal = {ACS Nano Medicine},
  year = {2026},
  volume = {1},
  number = {1},
  pages = {74--96},
  doi = {10.1021/acsnanomed.5c00021}
}
Kostenlos starten →